Pharma Solutions is the contract development and manufacturing (CDMO) division of Piramal | Healthcare, a part of the Piramal Enterprise. We are one of the largest custom manufacturing companies in the world that provides flexibility and scalability of operations. We have created a vast network of contract development and manufacturing facilities located in North America, Europe and Asia that offers a multitude of services that cover the entire drug-cycle, from development and commercial manufacturing to off-patent supplies of Active Pharmaceutical Ingredients (APIs) and formulations. Our network enables us to deliver benefits by strategically placing projects to take advantage of low costs, local supply chains and specific customer/ market requirements. This division features among the top 10 contract drug manufacturers in the world.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Uniphar Group is a trusted global partner to pharmaceutical, medtech, and supply chain and retail companies, working to improve patient access to medicines around the world.
Company Details
Latest Content from PMHub
Press Releases | November 10, 2026 | Medscape Education
MERCER COUNTY, NJ — Recognizing that clinical excellence and patient experience are inseparable, Medscape Oncology served as the official Caregiver Central Sponsor in support of Blood Cancer United’s Mercer County...
Press Releases | November 10, 2026 | Genesis Research Group
Genesis Research Group (Genesis) launches Keystone, its modular platform for Integrated Evidence Generation Planning (IEGP), at ISPOR Europe 2026.
Press Releases | November 10, 2026 | Emotive—Powered by Petauri
Acquisition strengthens Petauri's medical communications collective, Petauri Advance, with expanded global scale and deep scientific, strategic, and creative expertise.
Press Releases | November 9, 2026 | Medscape Education
"The view from the top is always better with the people who helped us get there."
White Papers and Resources | November 9, 2026 | Amiculum
What does a high-value medical affairs organization look like in a world of constrained resources, increasingly capable artificial intelligence (AI) and easier access to scientific information? For medical affairs leaders...
White Papers and Resources | November 3, 2026 | Inizio
AI is creating a world of opportunities for pharma companies to deliver more personalized HCP and patient engagement. But realizing the full potential of AI takes more than just introducing...
White Papers and Resources | November 3, 2026 | Inizio
Volatility is reshaping the conditions for successful product launches. Market dynamics can shift quickly, assumptions can change, and teams are increasingly expected to make confident decisions in response.
White Papers and Resources | November 3, 2026 | Inizio
The life sciences industry is changing fast. Advances in AI, increasingly complex science, shifting market dynamics and evolving patient needs are creating new challenges for organizations developing and commercializing treatments....
Press Releases | November 3, 2026 | Inizio
Inizio has appointed Oisín Ó Gógáin as Chief People Officer.
Press Releases | October 30, 2026 | Medscape Education
Medscape Education receives National Scleroderma Foundation’s Rocky Mountain Chapter's “Partner of Hope Award” for empowering the patient voice and shortening the diagnostic journey. This recognition honors Medscape Education’s significant commitment...